 REHOVOT, Israel, Oct. 14, 2021 PRNewswire - CollPlant Biotechnologies Nasdaq: CLGN, a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that the Companys Deputy CEO Chief Financial Officer Eran Rotem, will present a company overview at the Dawson James 6th Annual Small Cap Growth Conference at the Wyndham Grand Hotel in Jupiter, Florida. Mr. 